当前位置:首页 >财报库 > 报告详情

嘉德诺Cardinal Health(CAH) 2025财年第二季度财报「NYSE」(英文版)(50页).pdf

上传人: Kell****reet 编号:653914 2025-02-20 50页 676.84KB

下载:

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended December 31,2024orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHA

2、NGE ACT OF 1934For the transition period from.to.Commission File Number:1-11373Cardinal Health,Inc.(Exact name of registrant as specified in its charter)Ohio31-0958666(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.)7000 Cardinal Place,Dublin,Ohio43017(Add

3、ress of principal executive offices)(Zip Code)(614)757-5000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon shares(without par value)CAHNew York Stock Exchan

4、geIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject tosuch fili

5、ng requirements for the past 90 days.Yes No oIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that th

6、e registrant was required tosubmit such files).Yes No oIndicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reportingcompany,or an emerging growth company.See the definitions of“large accelerated filer,”“accelerated filer,”

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文是Cardinal Health, Inc.(以下简称“Cardinal Health”)提交给美国证券交易委员会(SEC)的2025财年第二季度10-Q报告。报告内容包括: 1. 财务数据:2025财年第二季度,Cardinal Health的总收入为552.64亿美元,较2024财年同期下降4%。其中,药品和专科解决方案(Pharma)部门收入为508.49亿美元,同比下降4%;全球医疗产品和服务(GMPD)部门收入为31.54亿美元,同比增长1%;其他部门收入为12.83亿美元,同比增长13%。 2. 经营业绩:2025财年第二季度,Cardinal Health的GAAP经营收益为5.49亿美元,同比增长9%;非GAAP经营收益为6.35亿美元,同比增长9%。GAAP稀释每股收益为1.65美元,同比增长10%;非GAAP稀释每股收益为1.93美元,同比增长2%。 3. 现金及现金等价物:截至2025财年第二季度末,Cardinal Health的现金及现金等价物为38亿美元,较2024财年同期减少13亿美元。 4. 重大事件:2025财年第二季度,Cardinal Health完成了对ION的收购,并宣布了收购GIA和ADSG的计划。此外,Cardinal Health还完成了11亿美元的债务融资,用于支持这些收购计划。 5. 风险因素:Cardinal Health在报告中提到了多项可能影响其未来业绩的风险因素,包括市场竞争、供应链问题、监管变化、诉讼风险等。 综上所述,Cardinal Health在2025财年第二季度实现了稳健的业绩增长,同时积极布局医疗保健领域,通过收购扩大业务范围。然而,公司也面临诸多外部风险,可能对其未来业绩产生影响。
2024年第二季度卡迪纳尔健康公司收入下降的原因是什么? 2024年第二季度卡迪纳尔健康公司的非GAAP经营收益为何增长? 2024年第二季度卡迪纳尔健康公司的现金及等价物余额为何减少?
客服
商务合作
小程序
服务号
折叠